Arctic Bioscience (Norway) Probability of Future Stock Price Finishing Over 1.8624
| ABS Stock | NOK 2.06 0.04 1.98% |
Arctic |
Arctic Bioscience Target Price Odds to finish over 1.8624
The tendency of Arctic Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above 1.86 in 90 days |
| 2.06 | 90 days | 1.86 | about 79.64 |
Based on a normal probability distribution, the odds of Arctic Bioscience to stay above 1.86 in 90 days from now is about 79.64 (This Arctic Bioscience AS probability density function shows the probability of Arctic Stock to fall within a particular range of prices over 90 days) . Probability of Arctic Bioscience price to stay between 1.86 and its current price of 2.06 at the end of the 90-day period is about 1.06 .
Assuming the 90 days trading horizon Arctic Bioscience has a beta of 0.62. This suggests as returns on the market go up, Arctic Bioscience average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Arctic Bioscience AS will be expected to be much smaller as well. Additionally Arctic Bioscience AS has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Arctic Bioscience Price Density |
| Price |
Predictive Modules for Arctic Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Arctic Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Arctic Bioscience Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Arctic Bioscience is not an exception. The market had few large corrections towards the Arctic Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Arctic Bioscience AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Arctic Bioscience within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.4 | |
β | Beta against Dow Jones | 0.62 | |
σ | Overall volatility | 5.43 | |
Ir | Information ratio | -0.1 |
Arctic Bioscience Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Arctic Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Arctic Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Arctic Bioscience generated a negative expected return over the last 90 days | |
| Arctic Bioscience has high historical volatility and very poor performance | |
| Arctic Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 21.52 M. Net Loss for the year was (42.58 M) with profit before overhead, payroll, taxes, and interest of 5.8 M. | |
| Arctic Bioscience generates negative cash flow from operations | |
| About 55.0% of the company shares are held by company insiders |
Arctic Bioscience Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Arctic Stock often depends not only on the future outlook of the current and potential Arctic Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arctic Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 24.3 M | |
| Short Long Term Debt | 4185.00 | |
| Shares Float | 23.2 M |
Arctic Bioscience Technical Analysis
Arctic Bioscience's future price can be derived by breaking down and analyzing its technical indicators over time. Arctic Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Arctic Bioscience AS. In general, you should focus on analyzing Arctic Stock price patterns and their correlations with different microeconomic environments and drivers.
Arctic Bioscience Predictive Forecast Models
Arctic Bioscience's time-series forecasting models is one of many Arctic Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Arctic Bioscience's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Arctic Bioscience
Checking the ongoing alerts about Arctic Bioscience for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Arctic Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Arctic Bioscience generated a negative expected return over the last 90 days | |
| Arctic Bioscience has high historical volatility and very poor performance | |
| Arctic Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 21.52 M. Net Loss for the year was (42.58 M) with profit before overhead, payroll, taxes, and interest of 5.8 M. | |
| Arctic Bioscience generates negative cash flow from operations | |
| About 55.0% of the company shares are held by company insiders |
Other Information on Investing in Arctic Stock
Arctic Bioscience financial ratios help investors to determine whether Arctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arctic with respect to the benefits of owning Arctic Bioscience security.